MTEM Molecular Templates Corporation Earnings per share growth in current year

Official company branding of Molecular Templates (MTEM)

Molecular Templates is developing a platform for the targeted destruction of tumor proteins through toxin modification, leveraging R&D patent protection. The distribution of the annual change in earnings per share reflects management efficiency, with the latest mark standing at 0.00. Simultaneously, the company is implementing green energy and water purification, although workforce reductions and the suspension of tests have seriously weakened its technological advantage.

mtem.com (MTEM) Net earnings per share growth this year: for the period 07/04/2022 - 12/28/2024

Analytical breakdowns and data insights for company Molecular Templates Corporation (MTEM)

- current price and projected stock value:
Quote Chart Molecular Templates Corporation|MTEM - Price Target Chart
- market capitalization data:
Market Value Molecular Templates|MTEM - Enterprise Value
- book capitalization indicators:
Book Value per Share Molecular Templates|MTEM - Company Net Assets|Market Cap to Book Value Multiple mtem.com|MTEM - Company Total Assets
- debt burden and liquidity indicators:
Aggregate Debt to Equity Molecular Templates|MTEM - Long-Term Debt to Equity|Current Liabilities to Capital Molecular Templates Inc|MTEM - Company Debts|Debt to Net Assets Ratio Molecular Templates, Inc.|MTEM - Company Long-Term Debt|Company Current Liabilities Molecular Templates|Interim Coverage Ratio mtem.com
- earnings and market multiples details:
MTEM - Company Net Income|Future Profit Molecular Templates|MTEM - Price to Earnings Ratio|Projected Price to Earnings Ratio mtem.com|MTEM - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Molecular Templates|MTEM - Operating profit EBITDA|Net earnings per one share for the last twelve months Molecular Templates|MTEM - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months mtem.com|MTEM - Net earnings per share growth this year|Earnings growth forecast for next year Molecular Templates
- company sales and revenue statistics:
MTEM - Company Revenue|Company Projected Revenue Molecular Templates Corp|MTEM - P/S Multiple|Forward P/S Multiple Molecular Templates, Inc.
Basic company analysis:Molecular Templates Corporation (MTEM)
Product sample of Molecular Templates Corp

For Molecular Templates (MTEM), which is developing targeted cancer therapies alongside biopharmaceutical giants, the effectiveness of its R&D strategy directly impacts profitability. The EPS growth dynamics compared to last year calculate the percentage deviation of current earnings per share from the same period last year, updating the data daily. This approach allows investors to perform a real-time assessment of the financial returns from partnerships without waiting for official quarterly reports.

Main competitors

Earnings per share trend in current year GERN (Geron Bio)|Earnings per share growth in current year Nanobiotix S.A.|Earnings per share growth in current year BCYC|Earnings growth in current year CTMX|Earnings growth in current year Perspective Therapeutics Inc (CATX)|Genelux - Net earnings per share growth this year|Net earnings per one share growth for the current year MOLN (Molecular Partners)|Oncolytics Biotech Inc. - Earnings growth in current year|Earnings per share trend in current year LSTA|moleculin.com (MBRX) - Earnings per share growth in current year|Earnings per share growth rate in current year Galera (GRTX)